European Leukemia Trial Registry
Trial: FAsciNation

More Details
Title Phase II Studie zu Asciminib bei CML in chronischer Phase
Scientific Title Frontline Asciminib Combination in Chronic Phase CML
Short Title FAsciNation
Trialgroup CML-Studiengruppe
Disease Chronic myeloid leukemia(CML) Chronic Phase
Age >= 18 years
Status Active
Start of Recruitment 10.10.2019
Leader Ernst, PD Dr. med. habil., Thomas
Shortprotocol Shortprotocol
created 02.12.2019 Zenawit Krüger
changed 20.02.2020 Zenawit Krüger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |